NOTRIXUM®
(atracurium besilate)
HONG KONG MEDICAL SUPPLIES LTD
HK Reg. No. HK68565, HK68566 (11 Feb, 2025)
Composition:4
• One ampoule with 2.5 ml solution contains 25 mg atracurium besilate
• One ampoule with 5 ml solution contains 50 mg atracurium besilate
Indication:4
• Notrixum is used as an adjunct to general anesthesia or sedation in the intensive care unit (ICU), to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation
References
1. EMC. Letrozole 2.5 mg film-coated tablets SmPC. 30 December 2024. Available from: https://www.medicines.org.uk/emc/product/9957/smpc#gref. [Accessed 19 February 2025]. 2. Sinovac. 23-Valent Pneumococcal Polysaccharide Vaccine. Available from: https://www.sinovac.com/zh-cn/portfolio/ppv23. [Accessed 20 February 2025]. 3. FDA. IMDELLTRA® Highlights of Prescribing Information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761344s000lbl.pdf. [Accessed 20 February 2025]. 4. EMC. Atracurium besilate SmPC. 2 November 2023. Available from: https://www.medicines.org.uk/emc/product/951/smpc#gref. [Accessed 20 February 2025].
